-
-
Press release - 23/02/2021
The European Commission agreed on the successor of BBI JU – the Circular Bio-based Europe Joint Undertaking (CBE JU) in a legislative proposal adopted today. The new partnership between the EU and the Bio-based Industries Consortium (BIC) is expected to build on the success of BBI JU while stepping up its contribution to the EU’s climate targets, in line with the European Green Deal. The European Parliament and Council will now study the…
https://www.biooekonomie-bw.de/en/articles/pm/commission-gives-green-light-successor-bbi-ju
-
-
-
-
-
-
Press release - 26/01/2021
The University of Warmia and Mazury in Olsztyn, Polish partner of the BalticBiomass4Value project, published a report which maps biomass value chains for improved sustainable energy use in the Baltic Sea Region countries. The research focuses on the 9 Baltic Sea Region (BSR) countries: Denmark, Germany, Estonia, Finland, Latvia, Lithuania, Poland, Sweden, and Norway.
https://www.biooekonomie-bw.de/en/articles/pm/report-mapping-biomass-value-chains-improved-sustainable-energy-use-baltic-sea-region-countries-published
-
-
-
New method for analysing blood samples - 26/11/2020
Immunotherapy has greatly improved the survival chances of patients with malignant melanoma. A study has now begun at the Department of Dermatology at the University Hospital of Tübingen to develop a way to monitor the course of treatment as effectively as possible. It involves personalised monitoring using liquid biopsies in addition to conventional PET/CT examinations. This analysis procedure of blood samples could enable closer monitoring of…
https://www.gesundheitsindustrie-bw.de/en/article/news/personalised-therapy-monitoring-malignant-melanomas
-
-
Biochip systems - 02/09/2020
Dr. Peter Loskill and his team at the Fraunhofer Institute in Stuttgart and the University Hospital of Tübingen are developing what is known as an "organ-on-a-chip" (OoC). An OoC is a microfluidic system that simulates small functional units of organ tissue. OoCs can be used in different ways: in basic and pharmaceutical research as well as in clinical research and application, where they might render many animal experiments…
https://www.gesundheitsindustrie-bw.de/en/article/news/miniature-organs-great-potential
-
Affimed GmbH - 01/07/2020
In the fight against tumour cells, d Affimed GmbH from Heidelberg relies entirely on the weapons of the innate immune system. Affimed has developed special innate cell engagers, which are bispecific antibodies that recognise tumour cells and bring them together with natural killer cells and macrophages of the innate immune system, which then kill the tumour cells. Clinical trials using the AFM13 molecule are ongoing.
https://www.gesundheitsindustrie-bw.de/en/article/news/innate-cell-engager-fighting-against-cancer
-
-
-
-
-
Article - 16/04/2019
Liquid biopsy, the analysis of cancer biomarkers and circulating tumour cells in body fluids such as blood, is revolutionising the diagnosis and monitoring of cancer. It has also been possible to expand circulating tumour cells from the blood under laboratory conditions. It is expected that in the future, liquid biopsy will be able to precisely characterise tumour cells at every stage of a cancer.
https://www.gesundheitsindustrie-bw.de/en/article/news/tumour-monitoring-using-liquid-biopsy
-
Dossier - 15/04/2019
Plastic waste takes years to decompose and pollutes the environment. Nevertheless, plastics are an indispensable part of everyday life. It is therefore all the more important to find a meaningful alternative that is sustainable, environmentally friendly and has better properties and more functionality than conventional plastics. In addition, such an alternative should not be dependent in any way on fossil resources.
https://www.biooekonomie-bw.de/en/articles/dossiers/the-alternative-bioplastics
-
-
Article - 03/04/2019
A spin-off from the Ulm University of Applied Sciences is aiming to provide people whose hands have been paralysed due to accident or illness with a new kind of orthopaedic aid. Dominik Hepp and Tobias Knobloch are currently starting serial production of a hand orthosis prototype. The two medical engineers from Ulm, who founded HKK Bionics GmbH in 2017, plan to commence final tests in 2019.
https://www.gesundheitsindustrie-bw.de/en/article/news/hkk-bionics-empowers-hand-gripping-functions
-
Article - 02/04/2019
For many decades, glyphosate has been a common component of agricultural pesticides worldwide, although it is a controversial herbicide that may be harmful. The good news is that a more sustainable alternative is now in sight: researchers from the University of Tübingen have discovered a sugar molecule called 7-deoxy-sedoheptulose (7dSh) which inhibits the growth of plants and microorganisms, but appears to be completely harmless to human cells.
https://www.biooekonomie-bw.de/en/articles/news/simple-sugar-could-soon-compete-with-glyphosate
-
Article - 27/03/2019
Algae are frugal organisms. They require only light, water, minerals and carbon dioxide to be able to produce biomass. These properties will now be exploited economically in a two-year research project. Dr. Stefan Sebök from the University of Hamburg plans to study the holistic utilisation of degradation products of a biogas plant in Wallerstädten by linking them to land-based algae cultivation.
https://www.biooekonomie-bw.de/en/articles/news/residues-from-biogas-plants-as-feed-for-algae
-
Website address: https://www.biooekonomie-bw.de/en/search